본문으로 건너뛰기
← 뒤로

A Framework for Locally Imputing and Predicting Biomarker Trajectories Under Irregular Monitoring: Application to Chronic Myeloid Leukemia.

1/5 보강
Research square 📖 저널 OA 100% 2023: 1/1 OA 2025: 35/35 OA 2026: 42/42 OA 2023~2026 2026 OA
Retraction 확인
출처

Montano-Campos F, Heagerty P, Haupt E, Hahn E, Radich J, Bansal A

📝 환자 설명용 한 줄

Irregular monitoring and missing data limit the utility of longitudinal biomarkers in real-world practice.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Montano-Campos F, Heagerty P, et al. (2026). A Framework for Locally Imputing and Predicting Biomarker Trajectories Under Irregular Monitoring: Application to Chronic Myeloid Leukemia.. Research square. https://doi.org/10.21203/rs.3.rs-8420996/v1
MLA Montano-Campos F, et al.. "A Framework for Locally Imputing and Predicting Biomarker Trajectories Under Irregular Monitoring: Application to Chronic Myeloid Leukemia.." Research square, 2026.
PMID 41542066 ↗

Abstract

Irregular monitoring and missing data limit the utility of longitudinal biomarkers in real-world practice. We developed a generalizable framework that combines interval-aligned preprocessing, localized multiple imputation, and machine-learning forecasting to generate complete trajectories and predict future biomarker values under routine clinical conditions. Using BCR::ABL1 monitoring in chronic myeloid leukemia as a case study, we aligned measurements to 90-day intervals, applied a windowed, uncertainty-propagating imputation strategy, and trained recurrent neural network (RNN) and XGBoost models to forecast values three and six months ahead. Full Information models achieved RMSEs of 1.22-1.24 for 3-month predictions-well below the biomarker's observed variability-and maintained accuracy even when the most recent visit was intentionally omitted, simulating extended follow-up. This framework preserves local temporal structure, supports individualized monitoring decisions, and is directly adaptable to other continuous biomarkers measured under irregular real-world schedules.
🟢 PMC 전문 열기